Search This Blog

Thursday, February 6, 2025

Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis

 

PDUFA Target Action Date Set for August 12, 2025


Would be the First and Only Available Treatment for Bronchiectasis and First DPP1 Inhibitor, if Approved

https://www.prnewswire.com/news-releases/fda-grants-priority-review-to-insmeds-brensocatib-for-treatment-of-bronchiectasis-with-pdufa-target-action-date-set-for-august-12-2025-302369466.html

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)